Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Immunology Letters, 2025

Dynactin subunit 1 facilitates mast cell degranulation to drive food allergy pathogenesis

Zhao M., Zhang H., Liu Z. et al.

Blood Journal, 2025

Ruxolitinib Targets JAK-STAT Signaling to Modulate Neutrophil Activation in Refractory Macrophage Activation Syndrome

Ma Y., Chen X., Wang M. et al.

Allergy, 2025

Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins

Fehr D., Huynh‐Tran V., Maintz L. et al.

Brain and Behavior, 2025

Causal Relationships Between the Gut Microbiota, Inflammatory Cytokines, and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Analysis

Changqing L., Leying Y., Caiyun M. et al.

Discover Oncology, 2025

Exploring the causal relationship between immune factors and chondrosarcoma: a Mendelian randomization study

Xu T., Xiao W., Li W. et al.

European Journal of Endocrinology, 2025

Proteomic variation underlies the heterogeneous risk of metabolic dysfunction-associated steatotic liver disease for subsequent chronic diseases

Wu J., Wu G., Li J. et al.

Nature Communications, 2025

SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses

Nehar-Belaid D., Mejías A., Xu Z. et al.

Scientific Reports, 2025

The contribution of oral infectious diseases in lacunar stroke based on meta-analysis and Mendelian randomization study

Zheng Q., Xu T., Luo S. et al.

Frontiers in Immunology, 2025

Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology

Zhou X., Wang W., Chen L. et al.

Aging Cell, 2025

Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients

Mury P., Dagher O., Fortier A. et al.

Journal of the American Heart Association, 2025

IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion

Lindkvist M., Göthlin Eremo A., Paramel G. et al.

Journal of the American Heart Association, 2025

Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention

El‐Sabawi B., Tanriverdi K., Gajjar P. et al.

Journal of the American Heart Association, 2025

Systemic Changes in Adults With a Fontan Circulation: Insights From the Plasma Proteome

Kelly B., Ravndal M., Bach P. et al.

The Oncologist, 2025

First-in-human phase I open-label study of the anti–TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors

Gutierrez M., Tang S., Powderly J. et al.

The Oncologist, 2025

First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors

Powderly J., Gutierrez M., Balmanoukian A. et al.

Nature, 2025

Interferon-γ orchestrates leptomeningeal anti-tumour response

Remsik J., Tong X., Kunes R. et al.

Journal of Proteome Research, 2025

Dynamic Changes in Lymphocyte Subsets and Inflammation-Immune-Related Proteins in Patients with Thyroid Papillary Carcinoma before and after Radioactive Iodine Therapy

Zhang J., Shi L., Zhang Z. et al.

Scientific Reports, 2025

Dissecting immune-mediated pathways in rheumatoid arthritis: A multivariate mediation analysis of antibodies and circulating proteins

Niu J., Zhang P., Liu W. et al.

BMC Neurology, 2025

CD28+ CD45RA− CD8br AC mediated the effects of Interleukin- 6 on Alzheimer's disease: A Mendelian Randomization Study

Xu R., Gao Y.

Journal for ImmunoTherapy of Cancer, 2025

Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

Maldonado M., Gracia-Hernandez M., Le L. et al.

4555 publications